165 related articles for article (PubMed ID: 11553313)
1. Loss of tuberin, the tuberous-sclerosis-complex-2 gene product is associated with angiogenesis.
Nguyen-Vu PA; Fackler I; Rust A; DeClue JE; Sander CA; Volkenandt M; Flaig M; Yeung RS; Wienecke R
J Cutan Pathol; 2001 Oct; 28(9):470-5. PubMed ID: 11553313
[TBL] [Abstract][Full Text] [Related]
2. Loss of expression of tuberin and hamartin in tuberous sclerosis complex-associated but not in sporadic angiofibromas.
Fackler I; DeClue JE; Rust H; Vu PA; Kutzner H; Rütten A; Kaddu S; Sander CA; Volkenandt M; Johnson MW; Vinters HV; Wienecke R
J Cutan Pathol; 2003 Mar; 30(3):174-7. PubMed ID: 12641776
[TBL] [Abstract][Full Text] [Related]
3. Localization of tuberous sclerosis 2 mRNA and its protein product tuberin in normal human brain and in cerebral lesions of patients with tuberous sclerosis.
Kerfoot C; Wienecke R; Menchine M; Emelin J; Maize JC; Welsh CT; Norman MG; DeClue JE; Vinters HV
Brain Pathol; 1996 Oct; 6(4):367-75. PubMed ID: 8944308
[TBL] [Abstract][Full Text] [Related]
4. Phosphatidylinositol 3-kinase but not tuberin is required for PDGF-induced cell migration.
Irani C; Goncharova EA; Hunter DS; Walker CL; Panettieri RA; Krymskaya VP
Am J Physiol Lung Cell Mol Physiol; 2002 Apr; 282(4):L854-62. PubMed ID: 11880313
[TBL] [Abstract][Full Text] [Related]
5. Suppression of tumorigenicity by the wild-type tuberous sclerosis 2 (Tsc2) gene and its C-terminal region.
Jin F; Wienecke R; Xiao GH; Maize JC; DeClue JE; Yeung RS
Proc Natl Acad Sci U S A; 1996 Aug; 93(17):9154-9. PubMed ID: 8799170
[TBL] [Abstract][Full Text] [Related]
6. MCP-1 overexpressed in tuberous sclerosis lesions acts as a paracrine factor for tumor development.
Li S; Takeuchi F; Wang JA; Fuller C; Pacheco-Rodriguez G; Moss J; Darling TN
J Exp Med; 2005 Sep; 202(5):617-24. PubMed ID: 16129702
[TBL] [Abstract][Full Text] [Related]
7. Reduction of expression of tuberin, the tuberous-sclerosis-complex-gene-2 product in tuberous sclerosis complex associated connective tissue nevi and sporadic squamous and basal cell carcinomas.
Wienecke R; Klemm E; Karparti S; Swanson NA; Green AJ; DeClue JE
J Cutan Pathol; 2002 May; 29(5):287-90. PubMed ID: 12100629
[TBL] [Abstract][Full Text] [Related]
8. Developmental expression of the tuberous sclerosis proteins tuberin and hamartin.
Murthy V; Stemmer-Rachamimov AO; Haddad LA; Roy JE; Cutone AN; Beauchamp RL; Smith N; Louis DN; Ramesh V
Acta Neuropathol; 2001 Mar; 101(3):202-10. PubMed ID: 11307618
[TBL] [Abstract][Full Text] [Related]
9. Expression of the tuberous sclerosis complex gene products, hamartin and tuberin, in central nervous system tissues.
Gutmann DH; Zhang Y; Hasbani MJ; Goldberg MP; Plank TL; Petri Henske E
Acta Neuropathol; 2000 Mar; 99(3):223-30. PubMed ID: 10663963
[TBL] [Abstract][Full Text] [Related]
10. Morphology of cerebral lesions in the Eker rat model of tuberous sclerosis.
Wenzel HJ; Patel LS; Robbins CA; Emmi A; Yeung RS; Schwartzkroin PA
Acta Neuropathol; 2004 Aug; 108(2):97-108. PubMed ID: 15185103
[TBL] [Abstract][Full Text] [Related]
11. Tuberous sclerosis: immunohistochemistry expression of tuberin and hamartin in a 31-week gestational fetus.
Vinaitheerthan M; Wei J; Mizuguchi M; Greco A; Barness EG
Fetal Pediatr Pathol; 2004; 23(4):241-9. PubMed ID: 16095035
[TBL] [Abstract][Full Text] [Related]
12. Expression of the TSC2 product tuberin and its target Rap1 in normal human tissues.
Wienecke R; Maize JC; Reed JA; de Gunzburg J; Yeung RS; DeClue JE
Am J Pathol; 1997 Jan; 150(1):43-50. PubMed ID: 9006320
[TBL] [Abstract][Full Text] [Related]
13. Loss of function of the tuberous sclerosis 2 tumor suppressor gene results in embryonic lethality characterized by disrupted neuroepithelial growth and development.
Rennebeck G; Kleymenova EV; Anderson R; Yeung RS; Artzt K; Walker CL
Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15629-34. PubMed ID: 9861021
[TBL] [Abstract][Full Text] [Related]
14. Inactivation of the cyclin-dependent kinase inhibitor p27 upon loss of the tuberous sclerosis complex gene-2.
Soucek T; Yeung RS; Hengstschläger M
Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15653-8. PubMed ID: 9861025
[TBL] [Abstract][Full Text] [Related]
15. The GAP-related domain of tuberin, the product of the TSC2 gene, is a target for missense mutations in tuberous sclerosis.
Maheshwar MM; Cheadle JP; Jones AC; Myring J; Fryer AE; Harris PC; Sampson JR
Hum Mol Genet; 1997 Oct; 6(11):1991-6. PubMed ID: 9302281
[TBL] [Abstract][Full Text] [Related]
16. Tuberous sclerosis-associated lesions of the kidney, brain, and skin are angiogenic neoplasms.
Arbiser JL; Brat D; Hunter S; D'Armiento J; Henske EP; Arbiser ZK; Bai X; Goldberg G; Cohen C; Weiss SW
J Am Acad Dermatol; 2002 Mar; 46(3):376-80. PubMed ID: 11862172
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer.
O'Byrne KJ; Koukourakis MI; Giatromanolaki A; Cox G; Turley H; Steward WP; Gatter K; Harris AL
Br J Cancer; 2000 Apr; 82(8):1427-32. PubMed ID: 10780522
[TBL] [Abstract][Full Text] [Related]
18. Abnormal cortical cells and astrocytomas in the Eker rat model of tuberous sclerosis complex.
Takahashi DK; Dinday MT; Barbaro NM; Baraban SC
Epilepsia; 2004 Dec; 45(12):1525-30. PubMed ID: 15571510
[TBL] [Abstract][Full Text] [Related]
19. HMB-45 and tuberin in hamartomas associated with tuberous sclerosis.
Kimura N; Watanabe M; Date F; Kitamoto T; Kumura I; Horii A; Nagura H
Mod Pathol; 1997 Sep; 10(9):952-9. PubMed ID: 9310961
[TBL] [Abstract][Full Text] [Related]
20. Role of the tuberous sclerosis gene-2 product in cell cycle control. Loss of the tuberous sclerosis gene-2 induces quiescent cells to enter S phase.
Soucek T; Pusch O; Wienecke R; DeClue JE; Hengstschläger M
J Biol Chem; 1997 Nov; 272(46):29301-8. PubMed ID: 9361010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
